Pharmacological approaches towards rationalizing the use of endoparasitic drugs in small animals

Journal of Veterinary Pharmacology and Therapeutics

Volumn 29, Issue 6, 2006, Pages 443-457

  Sanchez Bruni, S F ^a   Jones, D G ^b   Mckellar, Q A ^c  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^b MOREDUN RESEARCH INSTITUTE   (United Kingdom)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; ANTIPARASITIC AGENT; ARECOLINE; AVERMECTIN; BENZIMIDAZOLE DERIVATIVE; BUNAMIDINE; DIETHYLCARBAMAZINE; EMODEPSIDE; EPSIPRANTEL; FEBANTEL; FENBENDAZOLE; IVERMECTIN; LEVAMISOLE; MEBENDAZOLE; MILBEMYCIN; MILBEMYCIN DERIVATIVE; MILBEMYCIN OXIME; MOXIDECTIN; NICLOSAMIDE; OXANTEL; OXFENDAZOLE; OXIBENDAZOLE; PEPTIDE DERIVATIVE; PIPERAZINE; PYRANTEL; SELAMECTIN; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

AGRANULOCYTOSIS; ANIMAL DISEASE; ARTICLE; ATAXIA; BEHAVIOR DISORDER; BLINDNESS; CESTODE; CESTODIASIS; DIARRHEA; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG METABOLISM; DRUG TARGETING; DYSPNEA; FILARIASIS; HELMINTH; HELMINTHIASIS; HOST; HUMAN; INFECTION CONTROL; LETHARGY; LUNG EDEMA; MYDRIASIS; NEUROTOXICITY; NONHUMAN; PARASITOSIS; PHARMACODYNAMICS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SEIZURE; SPASTIC PARESIS; STOMACH IRRITATION; TOXOCARA CANIS; TOXOCARIASIS; TREMOR; VETERINARY MEDICINE; VOMITING; WORM INFECTION; ZOONOSIS;

ANIMALS; ANTHELMINTICS; ANTIPARASITIC AGENTS; ANTIPROTOZOAL AGENTS; CATS; DOGS; DRUG ADMINISTRATION SCHEDULE; PARASITIC DISEASES, ANIMAL;

ANIMALIA;

EID: 33750580724     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2006.00806.x     Document Type: Article

References (89)

1. Altreuther, G., Borgsteede, F.H.M., Buch, J., Charles, S.D., Cruthers, L., Epe, C., Young, D.R. & Krieger, K.J. (2005a) Efficacy of a topically administered combination of emodepside and praziquantel against mature and immature Ancylostoma tubaeforme in domestic cats. Parasitology Research, 97, S51-S57.
2. Altreuther, G., Buch, J., Charles, S.D., Davis, W.L., Krieger, K.J. & Radeloff, I. (2005b) Field evaluation of the efficacy and safety of emodepside/praziquantel spot-on solution against naturally acquired nematode and cestode infections in domestic cats. Parasitology Research, 97, S58-S64.
3. Alvinerie, M., Sutra, J.F., Lanusse, C. & Galtier, P. (1996) Plasma profile study of moxidectin in a cow and its suckling calf. Veterinary Research, 27, 545-549.
4. Andersen, F.L., Loveless, R.M.& Jensen, L.A. (1975) Efficacy of bunamidine hydrochloride against immature and mature stages of Echinococcus granulosus. American Journal of Veterinary Research, 36, 673-675.
5. Baggot, J.D. & McKellar, Q.A. (1994) The absorption, distribution and elimination of anthelmintic drugs: the role of pharmacokinetics. Journal of Veterinary Pharmacology and Therapeutics, 17, 409-419.
6. Barr, S., Bowman, D., Heller, R. & Erb, H. (1993) Efficacy of albendazole against giardasis in dogs. American Journal of Veterinary Research, 54, 926-928.
7. Barr, S., Bowman, D. & Heller, R. (1994) Efficacy of fenbendazole against giardasis in dogs. American Journal of Veterinary Research, 55, 988-990.
8. Berardi, C. & Camarero, M. (2003) Tubo Digestivo. Motilidad. In Best & Taylor, Bases Fisiológicas de la Práctica Médica, 13th edn. Ed. Dvorkin, M. & Cardinali, D., Panamericana, Buenos Aires. pp. 509-522.
9. Bishop, B.F., Bruce, C.I., Evans, N.A., Goudie, A.C., Gration, K.A., Gibson, S.P., Pacey, M.S., Perry, D.A., Walshe, N.D. & Witty, M.J. (2000) Selamectin: a novel broad-spectrum endectocide for dogs and cats. Veterinary Parasitology, 91, 163-176.
10. Braithwaite, P., Robertes, M., Allan, R. & Watson, T. (1982) Clinical pharmacokinetics of high dose of mebendazole in patients treated for hydatid disease. European Journal of Clinical Pharmacology, 22, 161-169.
11. Cadiergues, M. & Franc, M. (1994) Le vermifugation des carnivores domestiques avec le pyrantel: donnees bibliographiques. Revue du Medicine Veterinaire, 145, 449-453.
12. Campbell, W. (1989) Use of ivermectin in dogs and cats. In Ivermectin and Abamectin, 1st edn. Ed. Campbell, W. pp. 245-259. Springer-Verlag, New York, USA.
13. Clark, J., Daurio, C., Plue, R., Wallace, D. & Longhofer, S. (1992) Efficacy of ivermectin and pyrantel pamoate combined in a chewable formulation against heartworm, hookworm and ascarid infections in dogs. American Journal of Veterinary Research, 53, 517-520.
14. Corwin, R.M., Green, S.P. & Keefe, T.J. (1989) Dose titration and confirmation tests for determination of cestodicidal efficacy of epsiprantel in dogs. American Journal of Veterinary Research, 50, 1076-1077.
15. Courtney, C. & Roberson, E. (1995) Chemotherapy of the parasite diseases. In Veterinary Pharmacology and Therapeutics, 7th edn. Ed. Richard Adam, H. pp. 885-1004. Iowa State University Press, Ames, Iowa, USA.
16. Daurio, C., Cheung, A., Jeffcoat, R. & Skelly, B. (1992) Bioavailability of ivermectin administered orally to dogs. Veterinary Research Communications, 16, 125-130.
17. Daurio, C., Roberson, E. & Seward, R. (1993) Efficacy of ivermectin in a beef-based chewable formulation against Ancylostoma caninum and Uncinaria stenocephala in dogs. Journal of Parasitology, 79, 768-770.
18. Delatour, P., Benoit, E., Garnier, F. & Besse, S. (1990) Chirality of the sulphoxide metabolites of fenbendazole and albendazole in sheep. Journal of Veterinary Pharmacology and Therapeutics, 13, 361-366.
19. Dickin, S.K., McTier, T.L., Murphy, M.G., Bond, R., Mason, I.S., Payne-Johnson, M., Smith, D.G., Evans, N.A., Jernigan, A.D. & Rowan, T.G. (2003) Efficacy of selamectin in the treatment and control of clinical signs of flea allergy dermatitis in dogs and cats experimentally infested with fleas. Journal of the American Veterinary Medical Association, 223, 639-644.
20. Eckert, J., Thompson, R.C., Bucklar, H., Bilger, B. & Deplazes, P. (2001) Efficacy evaluation of epsiprantel (cestex) against Echinococcus mutilocularis in dogs and cats. Berliner und Munchener Tierarztliche Wochenschrift, 114, 121-126.
21. Edwards, G. & Breckenridge, A. (1988) Clinical pharmacokinetics of anthelmintic drugs. Clinical Pharmacokinetics, 15, 67-93.
22. EMEA/MRL/807, 2001: http://www.emea.eu.int/pdfs/vet/mrls/ 080701en.pdf
23. Fink, D. & Porras, A. (1989) Pharmacokinetics of ivermectin in animals and humans. In Ivermectin and Abamectin, 1st edn. Ed. Campbell, W. pp. 113-130. Springer Verlag, NY, USA.
24. García Sacristán, A.G., Castejón Montijano, F., de la Cruz Palomino, L., Gonzalez Gallego, J., Murillo Lopez de Silanes, M. & Salido Ruiz, G. (1995). In Fisiología Veterinaria, 1st edn. Ed. Sacristan, A.G. pp. 528-563. Interamericana-McGraw-Hill, Mexico.
25. Gemmell, M.A., Johnstone, P.D. & Oudemans, G. (1977) The effect of niclosamide on Echinococcus granulosus, Taenia hydatigena and Taenia ovis infections in dogs. Research in Veterinary Science, 22, 389-391.
26. Genchi, C., Poglayen, G., Kramer, L.H., Venco, L. & Agostini, A. (2001) Efficacy of moxidectin for the prevention of adult heartworm (Dirofilaria immitis) infection in dogs. Parasitologia, 43, 139-141.
27. Georgi, J.R. (1987) Tapeworms. Veterinary Clinics of North American Animal Practice, 17, 1285-1305.
28. Giorgi, M., Meucci, E., Vaccaro, E., Mengozzi, G., Giusiani, M. & Soldani, G. (2003) Effects of liquid and freeze dried grape fruit juice on the pharmacokinetics of praziquantel and its metabolite 4′-hydroxy praziquantel in beagle dogs. Pharmacological Research, 47, 87-92.
29. Guerrero, J., McCall, J. & Genchi, C. (2002) The use of macrocyclic lactones in the control and prevention of heartworm and other parasites in dogs and cats. In Macrocyclic Lactones in Antiparasitic Therapy, 1st edn. Eds Vercruysse, J. and Rew, R. pp. 353-369. Common Agricultural Bureaux International (CABI) Publishing, NY, USA.
30. Harder, A. (2002) Chemotherapeutic approaches to nematodes: current knowledge and outlook. Parasitology Research, 88, 272-277.
31. Harder, A., Holden-Dye, L., Walker, R. & Wunderlic, F. (2005) Mechanisms of action of emodepside. Parasitology Research, 97, S1-S10.
32. Hennessy, D. (1993) Pharmacokinetic disposition of benzimidazole drugs in the ruminant gastrointestinal tract. Parasitology Today, 9, 329-333.
33. Hennessy, D. & Alvinerie, M. (2002) Pharmacokinetics of the macrocyclic lactones: conventional wisdom and new paradigms. In Macrocyclic Lactones in Antiparasitic Therapy, 1st edn. Eds Vercruysse, J. & Rew, R.. pp. 97-123. Common Agricultural Bureaux International (CABI) Publishing, NY, USA.
34. Hopper, K., Aldrich, J. & Haskins, S. (2002) Ivermectin toxicity in 17 Collies. Journal of Veterinary Internal Medicine, 16, 89-94.
35. Hsu, W.H. (1980) Toxicity and drug interactions of levamisole. Journal of the American Veterinary Medical Association, 15, 1166-1169.
36. IPS INCHEM, 2003: http://www.inchem.org/documents/jecfa/jecmono/ v33je02.htm
37. Jacobs, D. (1987) Anthelmintics for dogs and cats. International Journal for Parasitology, 17, 511-518.
38. Jacobs, D. (2000) Selamectin - a novel injectable endectocide for dogs and cats. Veterinary Parasitology, 91, 161-162.
39. Jeschke, P., Scherkenbeck, T., Bonse, G., Mencke, N., Harder, A., Londershausen, E., Bischoff, E., Müller, H. & Kurka, P. (1993) Preparation of Cyclic Depsipeptides with 18 Ring Atoms as Endoparasiticides. (Gev. Offen DE 43174581993 A1).
40. Jung, M., Saito, A., Buescher, G., Maurer, M. & Graf, J. (2002) Milbemycin oxime. In Macrocyclic Lactones in Antiparasitic Therapy, 1st edn. Eds Vercruysse, J. & Rew, R. pp. 51-74. CABI Publishing, NY, USA.
41. Kane, G.C. & Lipsky, J.J. (2000) Drug-grapefruit juice interactions. Mayo Clinical Proceedings, 75, 933-942.
42. Katz, M. (1977) Anthelmintics. Drugs, 13, 124-136.
43. Lacey, E. (1990) Mode of action of benzimidazoles. Parasitology Today, 6, 112-115.
44. Lanusse, C. & Prichard, R. (1993) Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants. Drug Metabolism Review, 25, 235-279.
45. Lanusse, C., Lifschitz, A., Virkel, G., Alvarez, L., Sánchez, S., Sutra, J.F., Galtier, P. & Alvinerie, M. (1997) Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle. Journal of Veterinary Pharmacology and Therapeutics, 20, 91-99.
46. Lo, P.K., Fink, D., Williams, J. & Blondinger, J. (1985) Pharmacokinetics studies of ivermectin: effects of formulation. Veterinary Research Communications, 9, 251-268.
47. Lok, J.B., Knight, D.H., Wang, G.T., Doscher, M.E., Nolan, T.J., Hendrick, M.J., Steber, W. & Heaney, K. (2001) Activity of an injectable, sustained-release formulation of moxidectin administered prophylactically to mixed-breed dogs to prevent infection with Dirofilaria immitis. American Journal of Veterinary Research, 62, 1721-1726
48. Lovell, R.A. (1990) Ivermectin and piperazine toxicoses in dogs and cats. Veterinary Clinical of North American Animal Practice, 20, 453-468.
49. Martin, R.J. (1997) Modes of action of anthelmintic drugs. The Veterinary Journal, 154, 11-34.
50. Martin, R.J., Clark, C.L., Trailovic, S.M. & Robertson, A.P. (2004) Oxantel is an N-type (methyridine and nicotine) agonist not an L-type (levamisole and pyrantel) agonist: classification of cholinergic anthelmintics in ascaris. International Journal for Parasitology, 34, 1083-1090.
51. Martindale: The Extra Pharmacopoeia (1993) 30th edn. Ed. Reynolds, J.E.F., pp. 51. The Pharmaceutical Press, London, UK.
52. Masimirembwa, C. & Haster, J.A. (1994) Characterization of praziquantel metabolism by rat liver microsomes using cytochrome P450 inhibitors. Biochemical Pharmacology, 48, 1779-1783.
53. McKellar, Q. & Scott, E. (1990) The benzimidazole anthelmintic agents: a review. Journal of Veterinary Pharmacology and Therapeutics, 14, 101-108.
54. McKellar, Q., Harrison, P., Galbraith, E. & Inglis, I. (1990) Pharmacokinetics of fenbendazole in dogs. Journal of Veterinary Pharmacology and Therapeutics, 13, 386-392.
55. McKellar, Q., Galbraith, E. & Baxter, P. (1993) Oral absorption and bioavailability of fenbendazole in the dog and the effects of concurrent ingestion of food. Journal of Veterinary Pharmacology and Therapeutics, 13, 223-227.
56. McKellar, Q., Gokbulut, C., Muzandu, K. & Benchaoui, H. (2002) Fenbendazole pharmacokinetics, metabolism and potentiation in horses. Drug Metabolism and Disposition, 30, 1230-1239.
57. McTier, T., McCall, J., Dzimiansky, M., Aguilar, R. & Wood, I. (1992a) Prevention of experimental heart worm infection in dogs with single oral doses of moxidectin. In Proceedings of the heartworm Symposium. Ed. Soll, M. pp. 165-168. American Heartworm Society, IL, USA.
58. McTier, T., McCall, J., Holmes, R., Greene, T., Strickland, J. & Aguilar, R. (1992b) Prevention of naturally acquired heartworm infection in heartworm-naïve beagles by oral administration of moxidectin ar an interval of either one or two months. In Proceedings of the Heartworm Symposium. Ed. Soll, M. pp. 169-178. American Heartworm Society, IL, USA.
59. McTier, T.L., Shanks, D.L., Jerrigan, A.D., Rowan, T.G., Jones, R.L., Murphy, M.G., Wang, C., Smith, D.G., Holbert, M.S. & Blagburn, B.L. (2000a) Evaluation of the effects of selamectin against adult and immature stages of fleas (Ctenocephalides felis felis) on dogs and cats. Veterinary Parasitology, 91, 201-212.
60. McTier, T.L., Shanks, D.J., Watson, P., McCall, J.W., Genchi, C., Six, R.H., Thomas, C.A., Dickin, S.K., Pengo, G., Rowan, T.G. & Jernigan, A.D. (2000b) Prevention of experimentally induced heartworm (Dirofilaria immitis) infections in dogs and cats with a single topical application of selamectin. Veterinary Parasitology, 91, 259-268.
61. Mealey, K., Bentjen, S., Gay, J. & Cantor, G. (2001) Ivermectin sensitivity in collies is associated with deletion mutation of the mdr 1 gene. Pharmacogenetics, 11, 727-733.
62. Murray, M., Hudson, A.M. & Yassa, V. (1992) Hepatic microsomal metabolism of the anthelmintic benzimidazole fenbendazole: enhanced inhibition of cytochrome P450 reactions by oxidized metabolites of the drug. Chemical Research Toxicology, 5, 60-66.
63. Nagy, J., Schipper, H.G., Koopmans, R.P., Butter, J.J., Van Boxtel, C.J. & Kager, P.A. (2002) Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability. American Journal of Tropical Medicine and Hygiene, 66, 260-263.
64. Orisakwe, O.E., Ilondu, N.A., Afonne, O.J., Ofoefule, S.I. & Orish, C.N. (2000) Acceleration of body clearance of diethylcarbamazine by oral activated charcoal. Pharmacology Research, 42, 167-170.
65. Orisakwe, O.E., Ilondu, N.D., Afonne, O.J., Ofoefule, S.I., Orish, C.N. & Agbasi, P.U. (2001) Effect of activated charcoal on diethylcarbamazine absorption in humans. American Journal of Therapeutics, 8, 7-9.
66. Paul, A., Tranquilli, W., Seward, R., Todd, K. & Di Pietro, J. (1987) Clinical observation in collies given ivermectin orally. American Journal of Veterinary Research, 48, 684-685.
67. Paul, A., Tranquilli, W. & Hutchens, D. (2000) Safety of moxidectin in avermectin sensitive Collies. American Journal of Veterinary Research, 61, 482-483.
68. Pharmaceutical Codex (1979). 11th edn. The Pharmaceutical Press, London, UK.
69. Plumb, D. (1995) Veterinary Drug Handbook, 2nd edn. pp. 384-391. Iowa State University Press, Ames, IA, USA.
70. Pulliam, J. & Preston, J. (1989) Safety of ivermectin in target animals. In Ivermectin and Abamectin, 1st edn. Ed. Campbell, W. pp. 149-161. Springer-Verlag, NY, USA.
71. Reinemeyer, C.R., Charles, S.D., Buch, J., Seltje, T., Altreuther, G., Cruthers, L., McCall, J.W., Young, D.R. & Epe, C. (2005) Evaluation of the efficacy of emodepside plus praziquantel topical solution against ascarid infections (Toxocara cati or Toxascaris leonine) in cats. Parasitology Research, 97, S41-S50.
72. Roberson, E. & Burke, M. (1982) Evaluation of granulated fenbendazole as a treatment of helminth infection in dogs. Journal of the American Veterinary Medicine Association, 180, 53-55.
73. Sánchez, S., Alvarez, L. & Lanusse, C. (1995) Kinetics of albendazole and its metabolites in plasma and abomasal fluids of cattle. Archivos de Medicina Veterinaria, 27, 23-31
74. Sánchez, S., Alvarez, L., Pis, A., Quiroga, M. & Lanusse, C. (1999) Differences in plasma ad abomasal kinetics of albendazole and its metabolites in calves grazed on pasture or fed a grain-based diet. Research in Veterinary Science, 66, 223-230.
75. Sánchez, S., Sallovitz, J., Savio, E., McKellar, Q. & Lanusse, C. (2000) Comparative plasma bioavailability of two dosage forms of albendazole in dogs. The Veterinary Journal, 160, 150-153.
76. Sánchez, S., Jones, D., Small, J. & McKellar, Q. (2003) Dexamethasone decreases plasma levels of the pro-chiral fenbendazole and its chiral and achiral metabolites in sheep. Xenobiotica, 33, 731-742.
77. Sarasola, P., Jernigan, A.D., Walker, D.K., Castledine, J., Smith, D.G. & Rowan, T.G. (2002) Pharmacokinetics of selamectin following intravenous, oral and topical administration in cats and dogs. Journal of Veterinary Pharmacology and Therapeutics, 25, 265-272.
78. Sharp, M.L. & McCurdy, H.D. (1985) Anthelmintic efficacy of febantel combined with praziquantel in dogs. Journal of the American Veterinary Medicine Association, 187, 254-255.
79. Shoop, W. & Soll, M. (2002) Ivermectin, abamectin and eprinomectin. In Macrocyclic Lactones in Antiparasitic Therapy, 1st edn. Eds Vercruysse, J. & Rew, R. pp. 1-29. CABI Publishing, NY, USA.
80. Shoop, W., Michael, B., Soll, M. & Clark, J. (1996) Efficacy of ivermectin and pyrantel pamoate combination against adult hookworm, Ancylostoma brazilense in dogs. Australian Veterinary Journal, 63, 84-85.
81. Soulsby, E.J. (1987) Parasitología de las enfermadades parasitarias en los animales domésticos, 7th edn. pp. 123. Nueva Editorial Interamericana, Mexico.
82. Thompson, R., Reynoldson, J. & Manger, B. (1991) In vitro and in vivo efficacy of epsiprantel against Echinococcus granulosus. Research in Veterinary Science, 51, 332-334.
83. Trejos, A., Szyfres, B. & Marchevsky, N. (1975) Comparative value of arecoline hydrobromide and bunamidine hydrochloride for the treatment of Echinococcus granulosus in dogs. Research in Veterinary Science, 22, 389-391.
84. Urquhart, G., Armour, J., Duncan, J., Dunn, A. & Jennings, F. (1991) Veterinary Parasitology, 1st edn. 1987, reprinted 1991. Longman Scientific and Technical, Harlow, UK, pp. 123.
85. Vanapalli, S.R., Hung, Y.P., Fleckenstein, L., Dzimianski, M.T. & McCall, J.W. (2002) Pharmacokinetics and dose proportionality of oral moxidectin in beagle dogs. Biopharmaceutics and Drug Disposition, 23, 263-272.
86. Watson, A.D., Sangster, N.C., Church, D.B. & Van Gogh, H. (1988) Levamisole pharmacokinetics and bioavailability in dogs. Research in Veterinary Science, 45, 411-413.
87. Witassek, F., Burkhardt, B., Eckert, J. & Bircher, J. (1981) Chemotherapy of alveolar echinococcosis: comparison of plasma mebendazole concentrations in animals and man. European Journal of Clinical Pharmacology, 20, 427-433.
88. Witassek, F., Allan, R.J., Watson, T.R., Woodth, W., Ammann, R. & Bircher, J. (1983) Preliminary observations on the biliary elimination of mebendazole and its metabolites in patients with echinococcosis. European Journal of Clinical Pharmacology, 25, 81-84.
89. Zajac, A., LaBranche, T., Donoghue, A. & Chu, T. (1998) Efficacy of fenbendazole in the treatment of experimental giardia infection in dogs. American Journal of Veterinary Research, 59, 61-63.